NR4A1 and breast carcinoma: Leithner et al.’ study (22) including 91 breast cancers adopted a multi-layer perceptron feed-forward artificial neural network (MLP-ANN) to differentiate the hormone receptor-positive from hormone receptor-negative BC based on multiparametric MRI images, yielding an overall median AUC of 0.69, with median accuracies of 64.7% in the training dataset and 60.0% in the validation dataset.